• Staying Healthy in a Tough Economy (PR Newswire)
   
• Caution Urged When Giving Kids Cold and Flu Meds (PR Newswire)
   
• First Nationwide Folic Acid Survey of Spanish-Speaking Women Finds Most Are Missing Benefits, March of Dimes Says (PR Newswire)
   
• AHP Recession Survey of Nonprofit Health Care Officials Finds Almost Half Expect Reduced Giving in 2009, Leading to Cuts in Hospital Construction and Equipment Purchases (PR Newswire)
   
• Jett Travolta and Kawasaki Disease: Separating Fact From Fiction (PR Newswire)
   
• Inexpensive Test Can Help Prevent Lung Cancer Caused By Radon (PR Newswire)
   
• Photo: New Yale University Prevention Research Center Study Finds Flat Belly Diet! Reduced Dangerous Visceral Belly Fat by 33% (PR Newswire)
   
• Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in Mice (PR Newswire)
   
• Bionovo Publishes Discoveries in Predictable Tissue Selectivity for Selective Estrogen Receptor Modulators Platform (PR Newswire)
   
• Health Robotics Announces Results of the European Union-Sponsored SafeChemo Project (PR Newswire)
   
• Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R) (PR Newswire)
   
• Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia (PR Newswire)
   
• Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF (PR Newswire)
   
• Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients (PR Newswire)
   
• Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute (PR Newswire)
   
• SXC Health Solutions announces contract with PharMerica (PR Newswire)
   
• Kaiser Permanente Provides Seed Funding to the Institute for Healthcare Improvement's New Open School for Health Professions (PR Newswire)
   
• Summa Health Network Announces Contract with MDdatacor to Support Multi-Insurer Health Care Quality Initiative; Initiative to Use Clinical Data to Supplement Claims Data and Enhance Outcomes (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs

 January 2, 2009

• Interpreter Association IMIA Starts Campaign to Promote Code of Ethics for Medical Interpreters Worldwide (PR Newswire)
   
• The National Parkinson Foundation Awards Five Grants for the Falls Prevention Initiative (PR Newswire)
   
• Department of Health Recognizes January As Cervical Health Awareness Month (PR Newswire)
   
• Parkinson's Disease Plays Havoc With Common Orthopaedic Conditions (PR Newswire)
   
• Study Shows Machine Perfusion Significantly Improves Transplant Results (PR Newswire)
   
• Texas Health Arlington Memorial Hospital Becomes First in Texas, One of Few Worldwide, to Receive Prestigious Chest Pain Center Designation (PR Newswire)
   
• Roche Purchases Shares in Tender Offer For Memory Pharmaceuticals Corp. (PR Newswire)
   
• Valeant Pharmaceuticals Completes Acquisition of Dow Pharmaceutical Sciences, Inc. (PR Newswire)

 December 31, 2008

• New Year's Resolution for Illinois Lawmakers: Fix Broken Health Care System (PR Newswire)
   
• Massive Cuts to Medicare Home Oxygen Therapy Benefit Taking Effect January 1 Creating Acute Anxiety Among Beneficiary and Provider Communities (PR Newswire)
   
• Coalition for Pulmonary Fibrosis Celebrates Landmark Year for Awareness, Advocacy, Research (PR Newswire)
   
• Women Using Compounded 'Bioidentical' Hormones Miss the Full Story About These Drugs (PR Newswire)
   
• Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum (PR Newswire)
   
• Labopharm Announces FDA Approval of Once-Daily RYZOLT(TM) (Tramadol HCL Extended Release Tablets) for Management of Moderate to Moderately Severe Chronic Pain (PR Newswire)
   
• FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C (PR Newswire)
   
• Schering-Plough Announces European Submission of Fertility Medicine Corifollitropin Alfa (PR Newswire)
   
• PriCara(R) Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches (PR Newswire)
   
• Imugene and Merial Establish Strategic Alliance (PR Newswire)
   
• Healthaxis and BPO Management Services, Inc. Announce Closing of Merger (PR Newswire)
   
• Scantek Medical Files for Chapter 11 Voluntary Bankruptcy and Receives Orders for the Sale of BreastCare(TM) (PR Newswire)
   
• China Medical Technologies Announces the Completion of the Sale of its HIFU Business (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs

• Economic Stress Taking Toll on Peoples' Health (PR Newswire)
   
• Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients (PR Newswire)
   
• Pegloticase BLA Filing Accepted for Priority Review by FDA (PR Newswire)
   
• Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R) (PR Newswire)
   
• Mylan's Matrix Receives Final FDA Approval for the Generic Version of the Antiretroviral Zerit(R) Capsules (PR Newswire)
   
• CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes' (PR Newswire)
   
• GlaxoSmithKline Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies, Inc. (PR Newswire)
   
• Health Systems Solutions and Emageon Extend Merger Closing (PR Newswire)
   
• EMC Receives Express Scripts' IT Supplier of the Year Award (PR Newswire)
   
• Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs

• African Americans to Reach Health Resolutions Through Search Your Heart (PR Newswire)
   
• Glaucoma Research Foundation Celebrates National Glaucoma Awareness Month (PR Newswire)
   
• Blue Cross and Blue Shield of Oklahoma Announces Autism Benefits (PR Newswire)
   
• 2008 Human Research Protection Award Recipients Announced (PR Newswire)
   
• LIFE Provides Emergency Humanitarian Aid to Gaza Civilians and Hospitals (PR Newswire)
   
• Technique for Creating Authentic Rat Embryonic Stem Cells Published in Cell (PR Newswire)
   
• Perrigo Announces FDA Final Approval for Ibuprofen PM (PR Newswire)
   
• St. Jude Ranked No. 1 Pediatric Oncology Hospital in National Magazine Survey (PR Newswire)
   
• The Children's Hospital of Philadelphia Named Number One Pediatric Hospital in the U.S. by Parents Magazine (PR Newswire)
   
• Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc. (PR Newswire)
   
• LCA-Vision Urges Stockholders to Take No Action Regarding the Joffe Group's Threatened Consent Solicitation (PR Newswire)
   
• Health Robotics Announces Partnership in the People's Republic of China With The Devon International Group (PR Newswire)
   
• NASDAQ Gives Dynatronics a Second Three-Month Extension for Minimum Bid Price Compliance (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs

December 25-26, 2008

• FDA Approves Ferring Pharmaceuticals' Degarelix (Generic Name) for Treatment of Advanced Prostate Cancer (PR Newswire)
   
• Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes (PR Newswire)
   
• Osteotech Takes Precautionary Measure (PR Newswire)
   
• Emageon Provides Further Update Regarding Merger Transaction (PR Newswire)

December 24,2008

• The American Nurses Association on Behalf of the Larger Nursing Community Announces the Release of a First of Its Kind Study on the Economic Value of Nursing (PR Newswire)
   
• Pennsylvania Attorney General Corbett Announces Settlement With a N.J. Motorized Wheelchair Manufacturer Over Alleged Deceptive Marketing (PR Newswire)
   
• Memory Pharmaceuticals Initiates Biomarker Study of R3487/MEM 3454 in Schizophrenia (PR Newswire)
   
• Cytokinetics Retains Development and Commercialization Rights to Ispinesib and SB-743921 (PR Newswire)
   
• Peregrine Pharmaceuticals Receives Notification of Extension to Regain Compliance With NASDAQ's Minimum Bid Price Rule (PR Newswire)
   
• Long Beach Network for Health Successfully Demonstrates Secure Electronic Exchange of Patient Clinical Information (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs